The short answer: TennCare covers medication-assisted treatment in Tennessee. Most TennCare members can access Suboxone, Sublocade, Brixadi, Vivitrol, or Acamprosate with little or no out-of-pocket cost when they work with an in-network outpatient clinic. Most people never get to that answer because they assume they cannot afford treatment, so they wait. That waiting is what this article is meant to stop.
Below: exactly which medications TennCare covers, how the BESMART program changes your access, what prior authorization actually means in practice, and what to do today if you or someone you love needs to start treatment. Restoration Recovery is CARF-accredited, in-network with all three TennCare managed care organizations (BlueCare Tennessee, UnitedHealthcare Community Plan, and Wellpoint/Amerigroup), and handles the coverage-navigation part of this from the very first call. Same-day appointments are available at most of our four clinics across Southeast Tennessee and Ringgold, Georgia.
Which MAT medications does TennCare cover?
TennCare's pharmacy benefit is managed through OptumRx. Understanding which tier each medication falls into determines whether you need prior authorization or can walk into treatment today with a preferred product.
Buprenorphine and Suboxone (buprenorphine/naloxone)
Generic buprenorphine/naloxone tablets and films are the preferred products on the TennCare preferred drug list (PDL) managed through OptumRx. Preferred generics do not require prior authorization for doses up to 24mg per day when prescribed by a BESMART-enrolled provider. The practical benefit for patients: you can start treatment without waiting for insurance approval.
Brand-name Suboxone film requires prior authorization unless there is a documented allergy to inactive ingredients in the preferred generic. The formulary preference for generics exists because they work identically and cost the system less. For the clinical details of how daily film or tablet treatment works at Restoration Recovery, see our Suboxone treatment page.
Long-acting injections: Sublocade, Brixadi, and Vivitrol
Sublocade is buprenorphine in an extended-release injectable form given once a month under the skin. It is covered under the TennCare medical benefit rather than the pharmacy benefit, which means it is administered at the clinic rather than filled at a retail pharmacy. Prior authorization is required. For patients who struggle with daily medication adherence, the monthly injection can be a major clinical advantage. See our Sublocade treatment page for the full clinical picture.
Brixadi is the other long-acting buprenorphine injection and offers flexible dosing schedules — weekly, every two weeks, or monthly — depending on clinical fit. Like Sublocade, it is covered under the medical benefit with prior authorization. Brixadi is useful when a patient needs faster time-to-stable-dose than Sublocade allows, or when the weekly option better matches their life and adherence pattern. See our Brixadi treatment page for details.
Vivitrol is the monthly naltrexone injection. At Restoration Recovery, Vivitrol is used for alcohol use disorder, not opioid use disorder. For TennCare members with alcohol use disorder, Vivitrol blocks the rewarding effects of alcohol, reduces cravings, and is a strong option for patients who are past acute withdrawal and want a non-buprenorphine path forward. TennCare covers Vivitrol with prior authorization as part of a comprehensive treatment plan that includes psychosocial support. See our Vivitrol treatment page.
Acamprosate for alcohol use disorder
Acamprosate is a daily oral medication for alcohol use disorder, typically started once a patient is abstinent. It reduces cravings and the discomfort that can drive early relapse. Acamprosate is on the TennCare preferred drug list and does not require prior authorization for most patients. For patients who are abstinent at initiation and want an oral option rather than a monthly injection, this is often the right fit. See our Acamprosate treatment page.
A note on methadone
Methadone maintenance for opioid use disorder is available only through licensed opioid treatment programs (OTPs), not at outpatient clinics like Restoration Recovery. If your clinical situation calls for methadone specifically, the appropriate path is through a licensed OTP rather than an office-based setting.
How the BESMART program changes your access
BESMART stands for Buprenorphine Enhanced Supports for Medication-Assisted Recovery Treatment. It is TennCare's framework for office-based buprenorphine treatment, and understanding it is the difference between straightforward medication access and unnecessary delays. You can read the official BESMART Program Description from TennCare for the full set of program requirements.
What BESMART is and why it exists
Providers who enroll in BESMART complete an attestation process with each managed care organization — BlueCare Tennessee, UnitedHealthcare Community Plan, or Wellpoint/Amerigroup. They commit to delivering coordinated care: psychosocial assessments, monthly counseling, regular drug screening, and care coordination. In exchange, they receive enhanced reimbursement and greater prescribing flexibility. The program was designed to expand access to buprenorphine through office-based settings while keeping treatment quality high. It rewards clinics that deliver real, comprehensive care rather than just writing prescriptions.
What BESMART unlocks for patients
Being treated at a BESMART-enrolled clinic directly affects what you can access without prior authorization. BESMART providers can prescribe preferred buprenorphine products for doses up to 24mg per day without PA. Nurse practitioners and physician assistants can prescribe under a BESMART-enrolled supervising physician, which significantly expands access at multi-provider clinics. Non-BESMART physicians face tighter limits: a 16mg per day maximum, a six-month cap on treatment duration, and no NP or PA prescribing.
Before your first appointment at any clinic, ask directly whether they are BESMART-enrolled with your specific TennCare plan. That single question tells you whether you will need prior authorization and how fast you can start.
What coordinated BESMART care looks like in practice
The BESMART model is a structured treatment program, not just a prescription benefit. Enrolled providers are required to complete a psychosocial assessment at intake, provide monthly counseling sessions, schedule office visits at least every two months during stable maintenance, conduct random drug screens at least eight times per year, and provide care coordination when clinically indicated. TennCare reimburses all of these components. For patients, this means you are receiving a full treatment program, not just a medication refill service.
Prior authorization rules and the OptumRx formulary
Most people hear "prior authorization" and assume it means a long wait before treatment can start. For TennCare MAT, the rules are more patient-friendly than that — especially for preferred products and BESMART-enrolled providers.
When you do NOT need prior authorization
Preferred generic buprenorphine/naloxone tablets and films do not require PA for doses up to 24mg per day at BESMART-enrolled providers. Even without BESMART enrollment, any TennCare provider can prescribe up to 16mg per day as a five-day induction supply once every six months without prior authorization. This is the single most useful piece of TennCare MAT coverage to know: a patient can start treatment on day one and receive medication at the pharmacy without waiting for insurance review.
When prior authorization IS required
Prior authorization applies for: non-preferred products like brand Suboxone film or Zubsolv, doses above 24mg per day, buprenorphine monoproduct without pregnancy or breastfeeding ICD-10 codes documented, NP or PA prescribers at non-BESMART clinics, Sublocade, Brixadi, and Vivitrol. PA forms are submitted to OptumRx by fax. The specific buprenorphine prior authorization form outlines the required documentation. Initial approvals typically last six months; reauthorization runs twelve months after that.
The key criteria reviewers look for on PA requests: an opioid use disorder diagnosis, BESMART enrollment where required, a controlled substance monitoring database review from the past six months, and no concurrent opioid or benzodiazepine prescriptions that would conflict.
Step therapy and quantity limits
TennCare expects providers to start with preferred generic products before moving to brand alternatives. If a patient has a documented allergy to inactive ingredients in the preferred product, that documentation must accompany the PA request. The quantity limit on the preferred formulary tier is 24mg per day. Going above that threshold requires clinical documentation and prior authorization regardless of BESMART status. The system has logic: generics first, brand only when necessary, higher doses only when clinically justified.
What TennCare covers at an outpatient MAT clinic
The medication benefit is one part of the picture. TennCare also covers the full spectrum of services that make outpatient MAT work as a treatment program rather than just a pill pickup.
Office visits, counseling, and peer support
TennCare covers intake assessments, follow-up office visits, individual counseling sessions, and certified peer support at enrolled outpatient MAT clinics. These services are billed through the outpatient behavioral-health benefit rather than the pharmacy benefit. Many TennCare members pay little to nothing out of pocket. BlueCare Tennessee, UnitedHealthcare Community Plan, and Wellpoint all emphasize low-to-no cost sharing for behavioral health care. The goal of the BESMART model is a comprehensive, affordable treatment program in which cost is not the reason someone stays sick.
Telehealth coverage for MAT
TennCare covers telehealth visits for MAT appointments under BESMART and standard outpatient billing. Buprenorphine can be prescribed via telehealth by providers enrolled in a TennCare MCO's BESMART network, where clinically appropriate. This matters for patients in rural areas of Southeast Tennessee and North Georgia who face geographic barriers to consistent in-person care. The prescription goes to the pharmacy; the visit happens on a phone or computer.
Hepatitis C care alongside addiction treatment
TennCare also covers direct-acting antiviral (DAA) treatment for hepatitis C, which cures HCV in 8 to 12 weeks at rates above 95%. TennCare currently requires prior authorization for DAA treatment but does not impose fibrosis-stage requirements or substance use restrictions as of 2026. For patients with co-occurring HCV and opioid use disorder, integrated care at a single outpatient clinic is dramatically more effective than referral-based split care. See our pillar guide on clinics that treat hepatitis C and addiction together.
Concrete steps to start MAT under TennCare today
The rules above are only useful if you act on them. Here is a clear path from reading this article to starting treatment.
Step 1: Verify your TennCare plan and pharmacy benefit
TennCare members are enrolled in one of three managed care organizations: BlueCare Tennessee, UnitedHealthcare Community Plan, or Wellpoint/Amerigroup. Each has its own BESMART provider network. Call the member services number on the back of your TennCare card and ask two questions: is the clinic you are considering in their BESMART network, and is your preferred MAT medication on the preferred drug list without prior authorization? That five-minute call can eliminate delays once you are sitting in the clinic. For the broader overview of accepted plans, see our insurance page.
Step 2: Confirm BESMART enrollment with the clinic
When you call a clinic, ask directly whether they are a BESMART-enrolled provider for your TennCare plan. That one question tells you whether you will have access to the full preferred formulary without PA delays, and whether NP or PA-led care is available. A clinic that cannot answer this question clearly is a yellow flag. A clinic that answers it immediately, explains the process, and offers a prompt appointment is the right choice. Restoration Recovery handles verification on the first call so you are not left figuring it out yourself.
Step 3: What to bring to your first appointment
Bring your TennCare ID card, a valid photo ID, a list of current medications, and any prior treatment history if you have it. The clinic will run a controlled substance monitoring database review on your behalf — you do not need to pull that yourself. Be honest during the psychosocial intake assessment. That conversation shapes your treatment plan and helps the provider make the right clinical decisions for you.
The coverage is there. The next step is yours.
TennCare covers medication-assisted treatment in Tennessee, and the coverage is broad for patients who work with the right provider. Suboxone, Sublocade, Brixadi, Vivitrol, and Acamprosate are all covered. The BESMART program exists specifically to make access easier and to remove prior authorization barriers for preferred medications. The system has rules, but once you understand preferred products and BESMART enrollment, most coverage obstacles disappear.
For anyone in the Chattanooga area who has been putting off treatment because of cost concerns, the coverage is likely already in place. Restoration Recovery works with TennCare members to navigate MAT coverage and get treatment started without unnecessary delays. Book a callback or call 423-498-2000 to confirm your coverage, ask about appointment availability, and take the first step. Recovery is not as out of reach as it can feel right now.
